4D Molecular Therapeutics' Series B Round

4D Molecular Therapeutics raised a round of funding on September 05, 2018.

4DMT is focused on gene therapy product research and development for patients with genetic diseases. The company's discovery platform Directed Vector Evolution enables patients to create customized ge…

Articles about 4D Molecular Therapeutics' Series B Round: